Exclusive access to monthly insights from the world’s most innovative cannabis
processor. Join over 7000+ subscribers world-wide.
Nextleaf Solutions CEO Paul Pedersen joined Steve Darling from Proactive to share news the company has added to their already impressive patent list with a U.S. Patent on the novel process for acetylating Cannabigerol and subsequent refinement of CBG-O-Acetate.
Pedersen shares more details about this patent and why they feel the CBG-derived prodrug produced under the patented process may hold significant potential as a therapeutic product based on research that CBG may be effective in the treatment of inflammation, pain, and nausea.
Exclusive access to monthly insights from Canada’s most innovative cannabis processor. Join over 7000+ subscribers world-wide!
By selecting yes, I certify that I am of legal age in my jurisdiction to consume cannabis.